Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma

BACKGROUND: This phase I study aimed to assess the safety, dose‐limiting toxicity (DLT), maximum tolerated dose (MTD) and preliminary effect of nanoparticle albumin‐bound (nab)‐paclitaxel in combination with concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hui, Li, Qiaoqiao, Chen, Baoqing, Xi, Mian, Makelike, Kanjiebubi, Liu, Shiliang, Hu, Yonghong, Zhu, Yujia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417080/
https://www.ncbi.nlm.nih.gov/pubmed/37334881
http://dx.doi.org/10.1002/cam4.6205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417080/
https://www.ncbi.nlm.nih.gov/pubmed/37334881
http://dx.doi.org/10.1002/cam4.6205

Ejemplares similares